Monkeypox infection presenting as genital rash, Australia, May 2022.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
06 2022
Historique:
entrez: 3 6 2022
pubmed: 4 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

Rapid diagnosis and whole genome sequencing confirmed a case of monkeypox in an HIV-positive individual receiving antiretroviral therapy. The patient had a normal CD4+ T-cell count and suppressed HIV viral load and presented with a genital rash in Melbourne, Australia after return from Europe in May 2022. He subsequently developed systemic illness and disseminated rash and 11 days after symptom onset, he was hospitalised to manage painful bacterial cellulitis of the genital area.

Identifiants

pubmed: 35656835
doi: 10.2807/1560-7917.ES.2022.27.22.2200411
pmc: PMC9164678
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Infect Dis. 2005 Dec 15;41(12):1742-51
pubmed: 16288398
J Infect Dis. 1987 Aug;156(2):293-8
pubmed: 3036967
Lancet Infect Dis. 2022 May 24;:
pubmed: 35623380

Auteurs

Yael Hammerschlag (Y)

Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.

Gina MacLeod (G)

Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.

Georgina Papadakis (G)

Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

Asiel Adan Sanchez (A)

Northside Clinic, North Fitzroy, Australia.

Julian Druce (J)

Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

George Taiaroa (G)

Department of Infectious Diseases, University of Melbourne, Melbourne, Australia.

Ivana Savic (I)

Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

Jamie Mumford (J)

Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

Jason Roberts (J)

Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

Leon Caly (L)

Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Department of Infectious Diseases, University of Melbourne, Melbourne, Australia.

Deborah Friedman (D)

Public Health Division, Victorian Government Department of Health, Melbourne, Australia.

Deborah A Williamson (DA)

Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Department of Infectious Diseases, University of Melbourne, Melbourne, Australia.

Allen C Cheng (AC)

Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.

James H McMahon (JH)

Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.
Department of Infectious Diseases, Monash Medical Centre, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH